DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
Norming
U
U
Department of Urology, South Hospital, Stockholm, Sweden.
D002278:Carcinoma in Situ / Q000453:epidemiology / Q000235:genetics*; D002295:Carcinoma, Transitional Cell / Q000453:epidemiology / Q000235:genetics*; D004273:DNA, Neoplasm; D005434:Flow Cytometry; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000235:genetics; D011003:Ploidies; D011379:Prognosis; D016019:Survival Analysis; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000235:genetics*
D004273:DNA, Neoplasm